Low IgG FBS is used in IgG Antibody production, in the propagation of organisms that are normally hindered by the presence of IgGs, or any project in which downstream results would be hindered by exogenous IgGs.
Sera is aseptically collected and processed in a cGMP facility
Each batch of raw serum is screened for endotoxin, residual hemoglobin concentration, and microbiological quality before being used in production
Batches of raw serum are pooled and continuously mixed prior to filtration to ensure consistent quality throughout the entire lot
Final lots are tested for endotoxin, hemoglobin, pH, mycoplasma, and growth promotion. Biochemical assays and virus testing are also available upon request
Low IgG FBS has reduced levels of IgG which may be required for commercial antibody production or specialised organism propagation